Researcher
Inès Dufait
- Keywords:Medicine
- Disciplines:Cancer therapy, Immunology not elsewhere classified, Cancer biology
Affiliations
- Translational Radiation Oncology and Physics (Research group)
Member
From1 Oct 2019 → Today - Radiation Therapy (Department)
Member
From1 Nov 2018 → Today - Clinical sciences (Department)
Member
From15 Dec 2020 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From6 Aug 2015 → 19 Dec 2018 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 31 Oct 2018 - Medical Imaging and Physical Sciences (Department)
Member
From1 Oct 2013 → 31 Dec 2013 - Faculty of Medicine and Pharmacy (Faculty)
Member
From13 Oct 2010 → 27 Jun 2013
Projects
1 - 1 of 1
- Myeloid-derived suppressor cells as a novel therapeutic target in colorectal cancerFrom1 Jan 2014 → 10 Apr 2018Funding: IWT personal funding - strategic basic research grants
Publications
1 - 10 of 25
- Ferroptosis: Frenemy of Radiotherapy(2024)
Authors: Lisa Kerkhove, Febe Geirnaert, Inès Dufait, Mark De Ridder
- Heat shock proteins and cellular senescence in humans(2023)
Authors: Mariam Hebishy, Cabirou Mounchili Shintouo, Inès Dufait, Florence Debacq-Chainiaux, Ivan Bautmans, Rose Njemini
- Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer(2023)
Authors: Lisa Kerkhove, Febe Geirnaert, Amir Laraki Rifi, Ka Lun Law, Adrian Gutierrez, Inge Oudaert, Cyril Corbet, Thierry Gevaert, Inès Dufait, Mark De Ridder
- Interpretability and Repeatability of Radiomic Features: Applied on In Vivo Tumor Models(2023)
Authors: Amir Laraki Rifi, Inès Dufait, Chaïmae El Aisati, Mark De Ridder, Kurt Barbé
Pages: 1-1 - Colorectal Cancer Immunotherapy: State of the Art and Future Directions(2023)
Authors: Alyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, Hajar Hazime, Inès Dufait, Jashodeep Datta, Saratchandra Singh Khumukcham, Mark De Ridder, Jatin Roper, Maria T. Abreu, et al.
Pages: 1103-1119 - Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions(2022)
Authors: Melissa Van De Gucht, Inès Dufait, Lisa Kerkhove, Cyril Corbet, Sven Luk De Mey, H. Jiang, Lun Law Ka, Thierry Gevaert, Olivier Feron, Mark De Ridder
- Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, Gil Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13 - Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells(2022)
Authors: Philipp Kalus, Jolien De Munck, Sarah Vanbellingen, Laura Carreer, Thessa Laeremans, Katrijn Broos, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, B Neyns, et al.
- Barriers in radiobiology(2022)
Authors: Sven de Mey, Mark De Ridder, Inès Dufait
Number of pages: 204 - Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells(2021)
Authors: Jens Tijtgat, Jolien De Munck, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Lorenzo Franceschini, Karine Breckpot, Joeri L Aerts, B Neyns, Sandra Tuyaerts